SAN JOSE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative ...
Case Western Reserve roboticist Roger Quinn, neuroscientist Hillel Chiel to lead $8 million, five-year National Science Foundation NeuroNex Network project seeking next level of control of ...
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the best small cap stocks with the highest upside. On October 15, Truist slashed the price target on PROCEPT BioRobotics Corporation ...
The next frontier in robotics will take inspiration from biology to design robots that are soft, smart, green and social. From microrobots for cancer treatment, to swarms powering warehouses, soft ...
PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to a loss of $0.5 per share a year ago.
Will PROCEPT BioRobotics Corporation (PRCT) Report Negative Earnings Next Week? What You Should Know
PROCEPT BioRobotics Corporation (PRCT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results